勝龍國際(01182.HK)建議實施股本重組
格隆匯4月26日丨勝龍國際(01182.HK)發佈公吿,董事會建議實施股本重組,當中包括以下事項:擬“20合1”合併股份;透過註銷公司繳足股本(以每股已發行合併股份0.19港元為限)削減公司的已發行股本,致使每股已發行合併股份的名義金額或面值由0.2港元削減至0.01港元的股本削減;及將每股面值0.2港元的法定但未發行合併股份拆細為20股每股面值0.01港元的經調整股份的股份拆細。
於本公吿日期,現有股份於聯交所的每手買賣單位為10,000股現有股份。視股本重組生效情況,建議將股份每手買賣單位由10,000股現有股份變更為5,000股經調整股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.